| J9271 | Injection, pembrolizumab, 1 mg | 18,400 | $40 | $791.2K |
| J0897 | Injection, denosumab, 1 mg | 6,360 | $20 | $114.5K |
| J2506 | Injection, pegfilgrastim, excludes biosimilar, 0.5 mg | 830 | $80 | $67.9K |
| 99214 | The provider sees an established patient for an office visit or other outpatient visit involving evaluation and management. The visit involves a moderate level of medical decision making, and/or the… | 570 | $100 | $57.7K |
| 96413 | Chemotherapy is a therapeutic procedure used for the treatment of cancer via the use of chemical agents. These chemical agents (drugs) work on the cancerous cells of the body to destroy them. These… | 520 | $110 | $55.7K |
| 99213 | The provider sees an established patient for an office visit or other outpatient visit involving evaluation and management. The visit involves a low level of medical decision making, and/or the… | 740 | $70 | $49.6K |
| 88185 | The lab analyst performs the technical component of a flow cytometry procedure using cell surface, cytoplasmic, or nuclear markers to characterize cells and aid clinicians in diagnosing patients with… | 1,940 | $20 | $36.9K |
| 85025 | A complete blood count (better known as a CBC) is a blood test request by a doctor that provides detailed information about various types of cells in a patient's blood. Usually a pathologist or a… | 2,250 | $10 | $18K |
| J9217 | Leuprolide acetate (for depot suspension), 7.5 mg | 120 | $140 | $16.5K |
| 99232 | The provider sees a patient for a subsequent hospital inpatient or observation care visit involving evaluation and management (E/M). The visit involves a moderate level of medical decision making or… | 230 | $70 | $15.4K |